Patients with CKD stage 3-4 previously stable can abruptly decline their GFR due to many possible conditions (infections, toxic injuries, etc) and enter dialysis earlier than predicted. Some authors consider this SORO-ESRD as special clinical and biologicial entity that require a more "agressive" attitude than what is routinely done in management of CKD patients.